1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Current Studies at Motherisk - not used: Control of Hypertension in Pregnancy Study
Almost 10% of pregnancies are complicated by high blood pressure (hypertension). Experts agree that blood pressure medication should be given to pregnant women with severe hypertension to protect them from stroke. However, for pregnant women with mild to moderate hypertension, it is not known whether blood pressure medication benefits mothers or babies, and treating blood pressure may cause poorer growth of the baby. Canadian obstetricians are divided on how to treat hypertension.
The Control of Hypertension In Pregnancy Study (CHIPS) will determine whether allowing the mother's blood pressure to be higher than normal during pregnancy, results in better growth of the baby before birth and health of the baby after birth, than does normalizing blood pressure by prescribing blood pressure medication.
CHIPS is funded by the Canadian Institutes of Health Research and coordinated by the University of British Columbia, Maternal Fetal Medicine Division, Department of Obstetrics & Gynaecology and the University of Toronto, The Centre for Mother, Infant, and Child Research.
To find out more email the CHIPS coordinating centre at firstname.lastname@example.org